Interestingly, one of the mechanisms of tumor cell adaptation to immune system pressure is associated with increased expression of programmed death-ligand 1 (PD-L1), a transmembrane protein known to suppress the activation of T-cells (Wang et al., 2016). The gene discussed is CD274; the disease is neoplasm.